Drug Type Small molecule drug |
Synonyms NGF/TrkA and BDNF/TrkB signaling enhancer (AlzeCure) |
Action modulators, activators, stimulants |
Mechanism BDNF modulators(Brain-derived neurotrophic factor modulators), TrkA activators(Nerve growth factor receptor Trk-A activators), TrkB stimulants(Neurotrophic tyrosine kinase receptor type 2 stimulants) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | Sweden | - | |
Alzheimer Disease | Preclinical | Sweden | - |